Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines
| Title: | Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines |
|---|---|
| Authors: | Nishi, Tatsuya a, Morita, Ayako b, Hara, Naofumi b, Makimoto, Go b, Ninomiya, Kiichiro c, Fujii, Masanori b, Rai, Kammei d, Ohashi, Kadoaki b, Hotta, Katsuyuki d, Tabata, Masahiro e, Togashi, Yosuke b, f, g, Maeda, Yoshinobu a, Ichihara, Eiki e, ⁎ |
| Source: | In Lung Cancer March 2025 201 |
| Database: | ScienceDirect |
| ISSN: | 01695002 |
|---|---|
| DOI: | 10.1016/j.lungcan.2025.108415 |
| Published in: | Lung Cancer |
| Language: | English |